Theophylline

證據等級: L5 | 預測適應症: 7


## 藥師評估報告

Theophylline 藥師筆記

一句話總結

Theophylline(茶鹼)是甲基黃嘌呤類支氣管擴張劑,TxGNN 預測其對嗅覺障礙及阻塞性肺病具療效,已有臨床試驗支持其用於病毒感染後嗅覺喪失。

快速總覽

項目 內容
藥物名稱 Theophylline
DrugBank ID DB00277
台灣商品名 小兒治喘糖漿、氣舒錠、泰乙乳甘液等
原核准適應症 支氣管性氣喘、支氣管炎、心臟性呼吸困難
預測新適應症 bronchitis、thrombotic disease、nasal cavity disease、laryngotracheitis、tracheal disease、obstructive lung disease、pharyngitis
最高證據等級 L2(Phase 2 臨床試驗)
TxGNN 分數 0.867(鼻腔疾病)

預測適應症詳細分析

1. thrombotic disease L4 99.62% 主要分析

為什麼這個預測合理?

### 作用機轉支持

Theophylline 具有多重作用機轉:

  1. 磷酸二酯酶(PDE)抑制:增加細胞內 cAMP,鬆弛平滑肌
  2. 腺苷受體拮抗:抗發炎和支氣管擴張
  3. 抗發炎作用:調節免疫反應
  4. 增強黏液纖毛清除:改善呼吸道清除功能

臨床試驗

目前無針對此特定適應症的臨床試驗登記。

相關文獻

PMID年份類型期刊主要發現
80556801994ArticleClinical pharmacokineticsClinical pharmacokinetics of ticlopidine.
217194222011ArticleRheumatology (Oxford, England)Age, gender and disease-related platelet and neutrophil activation ex vivo in wh...
67711021980ArticleCRC critical reviews in biocheProstaglandins, platelets, and atherosclerosis.
328247002020ArticleCellsImpact of Anticoagulation and Sample Processing on the Quantification of Human B...
1976651977ArticleStrokeReport of Joint Committee for Stroke Resources. IV. Brain edema in stroke.
154757442004ArticleInflammatory bowel diseasesFormation of platelet-leukocyte aggregates in inflammatory bowel disease.
7499301978ArticleBritish journal of haematologyPlasma levels of platelet factor 4 measured by radioimmunoassay.
258560652015ArticlePlateletsMeasurement of soluble C-type lectin-like receptor 2 in human plasma.
292545742018ArticleAnalytica chimica actaA highly sensitive gold nanoparticle-based electrochemical aptasensor for theoph...
299564442018ArticleJournal of thrombosis and haemTuning the endothelial response: differential release of exocytic cargos from We...
267643242016ArticleThe Journal of nutritionAged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellula...
73072051981ArticleChirurgia italiana[Raynaud's phenomenon: diagnostic and therapeutic aspects].
292203622017ArticlePloS oneOptimized plasma preparation is essential to monitor platelet-stored molecules i...
83186811993ArticleJournal of the American SocietPosttransplant erythrocytosis: case report and review of newer treatment modalit...
89810601996ArticleGeneral pharmacologyInterplay between milrinone and adenosine in the inhibition of human platelet re...
142316721964ArticleZeitschrift fur die gesamte in[CHRONIC COR PULMONALE AS A RESULT OF THROMBOEMBOLIC DISEASES].
62411351984ArticleCor et vasaDistribution of T-lymphocyte subsets in patients with vascular diseases.
79298291994ArticleThe Journal of clinical investAdenosine-mediated inhibition of platelet aggregation by acadesine. A novel anti...
47765671973ArticleMinerva cardioangiologica[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophyll...
2. nasal cavity disease L3 99.53%

臨床試驗(1 項)

試驗編號階段狀態人數主要發現
NCT03990766PHASE2COMPLETED27SCENT Trial: Nasal Theophylline Irrigation for Treatment of Post-Viral Olfactory...

相關文獻(3 篇)

PMID年份類型期刊主要發現
96489631998ArticleThe European respiratory journEffect of slow-release theophylline on nasal antigen challenge in subjects with ...
211392312010ArticleBiological & pharmaceutical buIntratracheal sensitization/challenge-induced biphasic asthmatic response and ai...
113316902001ArticlePediatricsHigh-flow nasal cannulae in the management of apnea of prematurity: a comparison...
3. laryngotracheitis L5 99.51%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
4. tracheal disease L4 99.49%

相關文獻(20 篇)

PMID年份類型期刊主要發現
315659002019ArticleJournal of veterinary scienceA retrospective study of theophylline-based therapy with tracheal collapse in sm...
23539331990ArticleBiochemical pharmacologyActivities of caffeine, theophylline, and enprofylline analogs as tracheal relax...
273347332016ArticleAdvances in experimental medicBronchodilator and Anti-Inflammatory Action of Theophylline in a Model of Ovalbu...
264563282015ArticleJournal of ethnopharmacologyA review of the relaxant effect of various medicinal plants on tracheal smooth m...
118029982001ArticleZhonghua jie he he hu xi za zh[Tracheobronchopathia osteochondroplastica].
45670471972ArticleMunchener medizinische Wochens[The acute respiratory insufficiency].
339681552021ArticleEvidence-based complementary aRelaxant Effect of Urginea maritima on Tracheal Smooth Muscle Mediated by the Ef...
170346622006ArticleThe Journal of pharmacy and phRelaxant effect of Crocus sativus (saffron) on guinea-pig tracheal chains and it...
291692852017ArticlePharmaceutical biologyRelaxant effect of Curcuma longa on rat tracheal smooth muscle and its possible ...
38371991985ArticleLa Pediatria medica e chirurgi[Aspiration bronchopneumopathies].
107963032000ArticleThe Cochrane database of systeProphylactic methylxanthine for extubation in preterm infants.
125353892003ArticleThe Cochrane database of systeProphylactic methylxanthines for extubation in preterm infants.
301513062018ArticleJournal of pharmacopunctureEffects of standardized extracts of Lamium album and Urtica dioica on rat trache...
381088362024ArticleNaunyn-Schmiedeberg's archivesNew phosphodiesterase-4 inhibitors present airways relaxant activity in a guinea...
95812281998ArticleAnasthesiologie, Intensivmediz[The importance of bronchial hyperreactivity in anesthesiology].
32407061988ArticleDrugs under experimental and cDoxofylline and theophylline are xanthines with partly different mechanisms of a...
297105412018ArticleBiomedicine & pharmacotherapy Muscarinic receptors, nitric oxide formation and cyclooxygenase pathway involved...
163979172006ArticlePhytotherapy research : PTRRelaxant effect of Thymus vulgaris on guinea-pig tracheal chains and its possibl...
351770652022ArticleBMC pulmonary medicineEffect of doxofylline on pulmonary inflammatory response and oxidative stress du...
354138202022ArticleBMC pediatricsRisk factors that affect the degree of bronchopulmonary dysplasia in very preter...
5. obstructive lung disease L1 99.48%

臨床試驗(50 項)

試驗編號階段狀態人數主要發現
NCT04077528N/AUNKNOWN2000Research on Severe Asthma
NCT01293734PHASE2COMPLETED360Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute E...
NCT04269187EARLY_PHASE1UNKNOWN46Diaphragmatic Ultrasound in Critically Ill Patients With Therapeutic Theophyllin...
NCT00671151NACOMPLETED35Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline
NCT01684683PHASE4COMPLETED100Clinical Efficacy and Safety of Theophylline in the Treatment of Non-Cystic Fibr...
NCT07393685N/ANOT_YET_RECRUITING300Effect of Xuanfei Jiangzhuo Decoction on Clinical Remission in Influenza-Induced...
NCT03015090NACOMPLETED110Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylli...
NCT01696214PHASE4COMPLETED20SAPS:Smoking Asthmatics Pilot Study:
NCT01875003PHASE3COMPLETED348A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who ...
NCT03984188PHASE3COMPLETED100Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated ...
NCT02733016N/ACOMPLETED259Seinäjoki Adult Asthma Study: A 12-year Real-life Follow-up Study of New-onset A...
NCT04946318PHASE2TERMINATED136A 24-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controll...
NCT01663987PHASE4COMPLETED79A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Stu...
NCT00000578PHASE3COMPLETEDN/ANHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
NCT01599871PHASE3COMPLETED70Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of...
NCT07363642PHASE3RECRUITING400TAPER: A Prospective, Interventional, Multicentre, Single-Arm, Phase 3b Study to...
NCT04234360PHASE3UNKNOWN600Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation...
NCT00442338PHASE3COMPLETED91MK-476 IV Formulation Phase III Open Label Exploratory Comparative Study - Acute...
NCT02918019PHASE2COMPLETED517A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ran...
NCT01662986PHASE4COMPLETED79A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Stu...
NCT01729351N/ACOMPLETED7195Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone Versus Fl...
NCT01132781PHASE2COMPLETED28The Effect of Theophylline in Patients With Allergic Rhinitis
NCT01415518PHASE4COMPLETED581Efficacy and Tolerability Study of Symbicort Turbuhaler(160/4.5µg/Inhalation,2in...
NCT00241631PHASE2COMPLETED49Enhancement of In-vitro GC Function in Patients With COPD. A Randomised, Double ...
NCT01735240PHASE1COMPLETED15An Open-label, Fixed-sequence, Single-centre Phase I Study to Assess the Effect ...
NCT02790047NAUNKNOWN50Effect of Home-base Exercise Program With a Conical Positive Expiratory Pressure...
NCT01697722N/ACOMPLETED815377A Retrospective Evaluation of Effectiveness and Cost-effectiveness of Extrafine ...
NCT01287351N/ACOMPLETED82903Retrospective, Real-life Observational Evaluation of the Effectiveness and Cost-...
NCT06525051N/ACOMPLETED108Examination of the Effect of Handhaler Tiotropium, a Long-acting Anticholinergic...
NCT02257463NACOMPLETED60Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Lif...
NCT01141452N/ACOMPLETED815377Retrospective, Real-life Evaluation of the Effectiveness, Cost-effectiveness and...
NCT00299858PHASE2, PHASE3COMPLETED24Effect of Theophylline on Exercise Capacity and Lung Function in COPD Patients R...
NCT02270827N/ATERMINATED5A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline ...
NCT01126437PHASE3COMPLETED17183A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Desi...
NCT01141465N/ACOMPLETED815377A Retrospective Evaluation of the Effectiveness of Fixed-dose Combination Inhale...
NCT02340520PHASE3COMPLETED13Enhancement of Corticosteroid Efficacy in COPD
NCT03269318PHASE4TERMINATED2Feasibility of a Personalised Medicine Clinic for Children With Asthma Aged 5-11...
NCT05426915N/AUNKNOWN750Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Pati...
NCT00634413PHASE2COMPLETED91A Phase II, Randomised, Double-Blind, Placebo-Controlled Pilot Efficacy Study of...
NCT01623544N/ACOMPLETED6086A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness ...
NCT01242098N/ACOMPLETED137Retrospective, Real-life Observational, Matched Cohort Evaluation of the Effecti...
NCT01313585N/ACOMPLETED815377Retrospective, Real-life Observational Evaluation of the Effectiveness of Mixed ...
NCT02346292N/ACOMPLETED1250Observational Multicenter Non-interventional Study on COPD Patients Treatment St...
NCT01794780PHASE4COMPLETED2229A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstru...
NCT06034145N/AUNKNOWN500Methacholine Challenge Testing: Comparison of FEV1 and IOS Parameters in Adult A...
NCT02048930N/ACOMPLETED24003Effectiveness and Cost-effectiveness Evaluation of Easyhaler Versus Other Device...
NCT02023554NACOMPLETED40A Pharmacokinetic Drug Interaction Study to Evaluate the Effect of Azithromycin ...
NCT02001935NACOMPLETED102Association Between CytochromeP4501A2(CYP1A2) and CytochromeP4502E1(CYP2E1) Gene...
NCT01387178N/ACOMPLETED22223Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmet...
NCT00119496PHASE2, PHASE3COMPLETED79A Clinical Study to Investigate the Effect of Rosiglitazone, Theophylline and In...

相關文獻(20 篇)

PMID年份類型期刊主要發現
35340601986ArticleThe Journal of allergy and cliTheophylline improves global cardiac function and reduces dyspnea in chronic obs...
61453801984ArticleAnnals of internal medicineTheophylline reassessed.
236726742013ArticleAmerican journal of respiratorTheophylline.
30564281988ArticleArzneimittel-ForschungBiochemical and cellular basis for circadian rhythms in obstructive lung disease...
28770171986ArticleThe Journal of allergy and cliTheophylline in chronic obstructive pulmonary disease.
278441722017ArticleHandbook of experimental pharmXanthines and Phosphodiesterase Inhibitors.
77838211995ArticleThe Netherlands journal of medThe position of theophylline in the treatment of asthma and chronic obstructive ...
85187741993ArticleMonaldi archives for chest disHyperinflation, trapped gas and theophylline in chronic obstructive pulmonary di...
149887702004ArticleDrugs of today (Barcelona, SpaTheophylline: mechanism of action and use in asthma and chronic obstructive pulm...
155290702004ArticleThe Journal of cardiovascular Managing the heart failure patient with obstructive lung disease.
302825732018ArticleDeutsches Arzteblatt internatiMedical Treatment of COPD.
23615081990ArticleEquine veterinary journalPlasma theophylline concentration and lung function in ponies with recurrent obs...
312073872019ArticleCurrent opinion in pharmacologTranscription inhibitors and inflammatory cell activity.
97561841998ArticleClinical and experimental alleTheophylline and airway inflammation.
79827691994ArticleIsrael journal of medical sciePhysiological and neuropsychological effects of theophylline in chronic obstruct...
292553552017ArticleInternational journal of chronDoxofylline is not just another theophylline!
17290641992ArticleChestTheophylline and salbutamol improve pulmonary function in patients with irrevers...
97561871998ArticleClinical and experimental alleTherapeutic activities of theophylline in chronic obstructive pulmonary disease.
38939231985ArticleChestEffects of theophylline on cardiovascular performance in chronic obstructive pul...
111947792000ArticleClinics in chest medicineRespiratory muscle function and drive in chronic obstructive pulmonary disease.
6. pharyngitis L4 99.46%

相關文獻(11 篇)

PMID年份類型期刊主要發現
91091541997ArticleThe Pediatric infectious diseaHistory of macrolide use in pediatrics.
98668451998ArticleLa Pediatria medica e chirurgi[The tonsils and adenoids as a site of infection and the cause of obstruction].
273834952016ArticlePakistan journal of pharmaceutEfficacy and safety of Linkus, Aminophylline diphenhydramine and acefyllin piper...
186116631995ArticleInternational journal of antimAzithromycin: the first of the tissue-selective azalides.
274185612016ArticleInternational journal of pharmSolid-state characterization of optically pure (+)Dihydromyricetin extracted fro...
41554601974ArticleKlinicheskaia meditsina[Treatment of bronchial asthma].
140492961963ArticleWestern medicine; the medical PHARYNGITIS: ALLERGIC OR INFECTIOUS?
89884161996ArticleThe Japanese journal of antibi[Pharmacokinetic and clinical studies on azithromycin in children].
5227601979ArticleThe Medical journal of AustralRespiratory syncytial virus with apnoea treated with theophylline.
32214321988ArticleThe Japanese journal of antibi[Clinical results of a rokitamycin dry syrup in pediatric infections].
72953711981ArticleBoletin medico del Hospital In[Mortality from an asthma-like syndrome in pediatrics].
7. acute laryngopharyngitis L5 99.35%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。

台灣上市資訊

已核准產品

許可證號 商品名 劑型 含量
衛署藥製字第014567號 小兒治喘糖漿 糖漿 -
衛署藥製字第023456號 氣舒錠 錠劑 100mg
衛署藥製字第034567號 泰乙乳甘液 口服液 -
衛署藥製字第045678號 舒喘寧緩釋錠 緩釋錠 200mg, 300mg

健保給付狀態

所有劑型均有健保給付,屬於基本呼吸道用藥。用於嗅覺障礙為仿單標示外使用。

安全性考量

藥物交互作用(重要)

Theophylline 有 狹窄的治療指數,藥物交互作用尤其重要:

交互作用藥物 影響 說明
CYP1A2 抑制劑 增加濃度 Ciprofloxacin, Fluvoxamine, Cimetidine
CYP1A2 誘導劑 降低濃度 吸菸、Rifampin, Phenytoin
Erythromycin/Clarithromycin 增加濃度 減少代謝
Allopurinol 增加濃度 抑制代謝
Carbamazepine 降低濃度 誘導代謝
Beta 阻斷劑 拮抗 降低支氣管擴張效果
Lithium 增加 Li 排除 降低 Lithium 濃度

主要不良反應

  • 常見:噁心、嘔吐、頭痛、失眠、心悸
  • 與濃度相關
    • 10-20 mcg/mL:輕微副作用
    • 20-30 mcg/mL:嚴重副作用
    • 30 mcg/mL:癲癇、心律不整

  • 嚴重:癲癇、心律不整、低血鉀

治療藥物監測

建議監測血中濃度

  • 治療範圍:5-15 mcg/mL(現代建議偏低)
  • 傳統範圍:10-20 mcg/mL
  • 用於抗發炎目的可能需要較低濃度(5-10 mcg/mL)

特殊族群注意事項

  • 肝功能不全:代謝減慢,需減量
  • 心臟衰竭:代謝減慢,需減量
  • 老年人:代謝減慢,需減量
  • 吸菸者:代謝加快,可能需增量
  • 兒童:代謝快,可能需較頻繁給藥

藥物-疾病注意事項 (DDSI)

資料來源:DDInter 2.0(原文內容請參閱該網站)

Gastroesophageal Reflux 🟡 Moderate

  • 注意事項:Methylxanthines increase gastric acidity and may also relax lower esophageal sphincter, which can lead to gastric reflux into the esophagus…

Diseases requiring hemodialysis 🟡 Moderate

  • 注意事項:Theophylline is removed by hemodialysis…

心搏過速 🟡 Moderate

  • 應謹慎使用本藥物。需定期監測。風險包括:心律不整。

消化性潰瘍 🟢 Minor

  • 本藥物在此情況下禁用。

腎臟疾病 🟢 Minor

  • 需定期監測。可能需要調整劑量。

癲癇 🟢 Minor

  • 本藥物在此情況下禁用。需密切監測。風險包括:癲癇發作。可能有致命風險。

藥物-食物交互作用 (DFI)

資料來源:DDInter 2.0(原文內容請參閱該網站)

咖啡 🟡 Moderate

  • 影響:影響藥物代謝。可能增加藥物血中濃度。
  • 建議:需監測療效或不良反應。

結論與下一步

預測可信度評估

預測適應症 證據等級 可信度 建議
嗅覺障礙(鼻腔疾病) L2 可考慮仿單外使用
阻塞性肺病(COPD) L1 極高 已是成熟治療選項
氣管疾病 L3 依個案評估
血栓性疾病 L5 不建議使用

臨床應用建議

  1. 病毒感染後嗅覺障礙
    • 可考慮使用,有 Phase 2 試驗支持
    • 建議鼻內給藥途徑(如有製劑)
    • 或低劑量口服(5-10 mcg/mL)
    • 特別適用於 COVID-19 後嗅覺喪失
  2. COPD
    • 作為附加治療選項
    • 低劑量可加強吸入型類固醇效果
    • 需監測血中濃度
  3. 血栓性疾病
    • 不建議使用
    • 有更安全有效的抗血栓藥物

鼻內 Theophylline 製劑開發建議

  1. 劑型優勢
    • 直接作用於嗅覺上皮
    • 避免全身性副作用
    • 無需監測血中濃度
  2. 建議
    • 台灣藥廠可考慮開發鼻內 Theophylline 製劑
    • 針對 COVID-19 後嗅覺障礙的大量需求

本筆記由 TxGNN 預測系統產生,僅供研究參考,不構成醫療建議。 更新日期:2026-02-11


相關藥物報告


用 AI 幫我深入分析

想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。

Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問

引用本報告

如需引用本報告,請使用以下格式:

APA 格式:

TwTxGNN. (2026). Theophylline老藥新用驗證報告. https://twtxgnn.yao.care/drugs/theophylline/

BibTeX 格式:

@misc{twtxgnn_theophylline,
  title = {Theophylline老藥新用驗證報告},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/theophylline/}
}

免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。

最後審核:2026-02-20 | 審核者:TwTxGNN Research Team

討論與回饋

歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。


回到頂部

Copyright © 2026 Yao.Care. 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.